STAT3 and hepatocellular carcinoma: The modulation of lipid metabolism through interaction with fatty acid-binding proteins and suppression of stearoyl-CoA desaturase (SCD) expression in lung cancer [9], and induction of ferroptosis via STAT3 inhibition in hepatocellular carcinoma (HCC) [10].